Century Health has raised an oversubscribed $5 million seed round led by Origin Ventures, with participation from InnovateHealth Ventures, 25madison, Next Play Ventures, 2048 Ventures, and Alumni Ventures to expand its AI-powered clinical data platform and grow partnerships across life sciences and pharmaceutical sectors.
The company’s Century Health Abstraction & Retrieval Model (CHARM) automates the curation and enrichment of fragmented clinical data to generate high-quality real-world evidence for therapeutic development and clinical research.
Click here to join our WhatsApp channel here
“Century Health is accelerating medical breakthroughs by unlocking real-world clinical data across the entire drug lifecycle, creating a win-win for providers and life sciences companies,” said Prashant Shukla, Partner at Origin Ventures. “Upstream, it’s the fuel for AI models driving discovery, disease modeling, and patient stratification; downstream, it’s the evidence needed to demonstrate safety and effectiveness, differentiate their drugs, and win payer negotiations.”
Century Health also reported significant growth in its provider data network across neurology, nephrology, ophthalmology, respiratory, metabolic, and immunology, supporting partnerships with multiple leading pharmaceutical companies.
“Structuring clinical data historically required extensive manual work that can now be automated and scaled, creating unprecedented opportunity for healthcare data infrastructure. Century Health operates with the speed the life sciences industry needs and the clinical rigor it demands. This funding lets us expand our network, go deeper into priority disease areas, and generate the critical evidence that shapes patient care,” said Vish Srivastava, Co-Founder and CEO of Century Health.
